product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
HSP90α (D1A7) Rabbit mAb
catalog :
8165
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D1A7
reactivity :
human, rat, cow
application :
western blot
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 1b
Huang Z, Zhou X, He Y, Ke X, Wen Y, Zou F, et al. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition. Sci Rep. 2016;6:38072 pubmed publisher
  • western blot; human
Goichon A, Bertrand J, Chan P, Lecleire S, Coquard A, Cailleux A, et al. Enteral delivery of proteins enhances the expression of proteins involved in the cytoskeleton and protein biosynthesis in human duodenal mucosa. Am J Clin Nutr. 2015;102:359-67 pubmed publisher
Patel K, Kollory A, Takashima A, Sarkar S, Faller D, Ghosh S. MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression. Cancer Lett. 2014;347:54-64 pubmed publisher
product information
SKU :
8165S
Product-Name :
HSP90α (D1A7) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, R, Hm, Mk, B, Pg, (Hr)
Applications :
Western blot
Product-Category :
Protein Folding and Trafficking
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
90
Host :
Rabbit
Target :
HSP90A
Primary-Protein :
HSP90A
Alt-Names :
FLJ31884,HS90A,HSP 86,HSP86,HSP89A,HSP90A,HSP90AA1,HSP90N,HSPC1,HSPCA,HSPCAL1,HSPCAL4,HSPN,Heat shock 86 kDa,Heat shock protein HSP 90-alpha,Hsp89,Hsp90,LAP2,Renal carcinoma antigen NY-REN-38,heat shock 90kD protein 1, alpha,heat shock 90kD protein 1, alpha-like 4,heat shock 90kD protein, alpha-like 4,heat shock 90kDa protein 1, alpha,heat shock protein 90kDa alpha (cytosolic), class A member 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.